다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Corgentech Inc. (MM) (CGTK)
Corgentech Inc. (MM) (CGTK) 뉴스

CGTK

Corgentech (CGTK)

Corgentech Inc. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CGTK

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2006/06/22	06:05	PR Newswire (US)	Corgentech Changes Name to Anesiva to Reflect Focus on Robust Pipeline of Pain Therapeutics	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/06/20	21:00	PR Newswire (US)	Corgentech Secures $30 Million Committed Equity Financing Facility	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/06/14	21:00	PR Newswire (US)	Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/06/07	21:00	PR Newswire (US)	Corgentech to Present at Pacific Growth Equities Life Sciences Growth Conference and Needham & Company Fifth Annual Biotechnolo	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/06/06	21:00	PR Newswire (US)	Corgentech Announces Appointment of K. Peony Yu as Vice President, Clinical Research and Michael Leong as Director, Clinical Re	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/05/30	21:30	PR Newswire (US)	Corgentech Announces Appointment of Susan Kramer as Vice President of Preclinical Development	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/05/23	04:00	PR Newswire (US)	Corgentech to Host Webcast Conference Call on Wednesday, May 24, 2006	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/05/18	21:30	PR Newswire (US)	Corgentech Announces Scientific Presentation of Pivotal Phase 3 Data Demonstrating Significant Pain Reduction Associated With F	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/05/05	06:02	PR Newswire (US)	Corgentech Announces First Quarter 2006 Financial Results	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/05/04	21:30	PR Newswire (US)	Corgentech Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief of Pain and improved function i	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/04/28	21:30	PR Newswire (US)	Corgentech Announces Presentation of 3268 Phase 3 Data at 2006 Pediatric Academic Societies' Annual Meeting	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/04/27	21:30	PR Newswire (US)	Corgentech to Announce First Quarter 2006 Financial Results and Host Webcast Conference Call on May 4, 2006	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/04/18	07:31	PR Newswire (US)	Corgentech Files Universal Shelf Registration	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/03/27	22:00	PR Newswire (US)	Corgentech to Present at CIBC World Markets' Annual Biotechnology and Specialty Pharmaceuticals Conference 2006	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/03/25	06:05	PR Newswire (US)	Corgentech Reports Phase 2 Trial Results for 4975 in Hernia Repair Pain	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/03/09	21:00	PR Newswire (US)	Corgentech Phase 2 Trial of ALGRX 4975 Meets Primary Endpoint of Decreased Pain for Tendonitis Patients	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/03/06	21:00	PR Newswire (US)	Corgentech Presents Clinical Data From Phase 1/2 Trial of Avrina(TM), Drug Candidate for Eczema	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/03/03	21:00	PR Newswire (US)	Corgentech to Webcast Presentation From Lehman Brothers 2006 Global Healthcare Conference	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/02/24	21:00	PR Newswire (US)	Corgentech to Webcast Presentation From 2006 Citigroup Global Health Care Conference	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/02/24	06:05	PR Newswire (US)	Corgentech Announces Fourth Quarter and Year-End 2005 Financial Results	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/02/18	06:05	PR Newswire (US)	Corgentech to Announce Fourth Quarter and Year-End 2005 Financial Results and Host Webcast Conference Call on February 23, 2006	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/02/09	21:00	PR Newswire (US)	Corgentech Completes Patient Enrollment in Three Phase 2 Clinical Trials of Post-Surgical Pain Drug Candidate	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/02/08	21:00	PR Newswire (US)	Corgentech to Webcast Presentation From 2006 BIO CEO and Investor Conference	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/02/08	07:00	PR Newswire (US)	Corgentech Reports Clinical Data From Phase 1/2 Trials of Avrina(TM), Drug Candidate for Eczema	NASDAQ:CGTK	Corgentech Inc. (MM)
2006/01/19	21:00	PR Newswire (US)	Corgentech Announces Management Promotions	NASDAQ:CGTK	Corgentech Inc. (MM)
2005/12/16	21:00	PR Newswire (US)	Corgentech and AlgoRx Complete Merger Creating Late-Stage Company Addressing Pain Management and Inflammation	NASDAQ:CGTK	Corgentech Inc. (MM)
2005/12/06	21:00	PR Newswire (US)	Corgentech and AlgoRx Complete Enrollment for Phase 1/2 Trial of Avrina(TM), New Drug Candidate for Eczema	NASDAQ:CGTK	Corgentech Inc. (MM)
2005/11/22	21:00	PR Newswire (US)	AlgoRx and Corgentech to Webcast Presentation From the Lazard Capital Markets 2005 Life Sciences Conference	NASDAQ:CGTK	Corgentech Inc. (MM)
2005/11/17	21:00	PR Newswire (US)	AlgoRx and Corgentech to Mail Definitive Proxy for Proposed Merger	NASDAQ:CGTK	Corgentech Inc. (MM)
2005/11/15	21:00	PR Newswire (US)	AlgoRx and Corgentech Announce Addition of Ninth Board Member to Proposed Board of Directors for Combined Company	NASDAQ:CGTK	Corgentech Inc. (MM)

검색 관련기사 보기:NASDAQ:CGTK

1 2 3 4 다음 >>

US Dollar vs Yen

Deutsche Telekom (QX)

BNP Paribas (QX)

Verizon Communications

American Express

Financial Select Sector

US Dollar vs Sterling

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관